Evaluation of the effectiveness of platelet-rich plasma therapy in the treatment of osteoarthritis compared to other treatment methods
DOI:
https://doi.org/10.56782/pps.231Keywords:
osteoarthritis, PRP, platelet-rich plasmaAbstract
Osteoarthritis is a common condition affecting a large proportion of the population. It is associated with a significant reduction in quality of life due to pain and limited joint mobility. There are many methods of treatment, among them conservative methods, pharmacological or surgical treatment can be mentioned. The purpose of this article is to analyze the effectiveness of intra-articular injections of platelet-rich plasma (prp) compared to other methods. Platelet-rich plasma is widely used in the treatment of osteoarthritis. Many sources prove its effectiveness in reducing pain, compared to injections of other substances, but there are also studies about the lack of sufficient evidence or the effect of prp similar to the placebo effect. The use of platelet-rich plasma is a promising method of treating osteoarthritis, however, further research and long-term observations are needed to introduce this method to the standards of treatment. The article was based on scientific publications in the Pubmed database. The database was searched on July 28 2023 using the phrases 'osteoarthritis', ‘PRP’, ‘Platelet-rich plasma’. After reading the titles of found articles, 39 publications were selected. After the pre-analysis of the abstracts, 15 full-text works were selected to prepare the article.
Downloads
References
1.Goodman, S. Osteoarthritis. In Expert Guide to Rheumatology, Yee, A., Paget, S., Eds.; American College of Physicians: Philadelphia, PA, USA, 2005; pp. 269–283.
2. Bansal, H.; Leon, J.; Pont, J.L.; Wilson, D.A.; Bansal, A.; Agarwal, D.; Preoteasa, I. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Sci. Rep. 2021, 11, Art. No: 3971. DOI: 10.1038/s41598-021-83025-2. Erratum in: Sci. Rep. 2021, 11, Art. No: 18612. DOI: https://doi.org/10.1038/s41598-021-83025-2
3. DiCesare, P.E.; Abramson, S.; Samuels, J. Pathogenesis of osteoarthritis. In Kelley's Textbook of Rheumatology, 8th ed.; Firestein, G.S.; Kelley, W.N., Eds.; Saunders Elsevier: Philadelphia, PA, USA, 2009; pp.1685-1704. DOI: https://doi.org/10.1016/B978-0-323-31696-5.00098-X
4. Cook, C.S.; Smith, P.A. Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee. Curr. Rev. Musculoskelet. Med. 2018, 11, 583-592. DOI: 10.1007/s12178-018-9524-x. DOI: https://doi.org/10.1007/s12178-018-9524-x
5. Manek, N.J.; Lane, N.E. Osteoarthritis: current concepts in diagnosis and management. Am. Fam. Physician. 2000, 61, 1795-1804.
6. Sinusas, K. Osteoarthritis: diagnosis and treatment. Am. Fam. Physician. 2012, 85, 49-56. Erratum in: Am. Fam. Physician. 2012, 86, 893.
7. Emami, A.; Tepper, J.; Short, B.; Yaksh, T.L.; Bendele, A.M.; Ramani, T.; Cisternas, A.F.; Chang, J.H.; Mellon, R.D. Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular. Int. J. Toxicol. 2018, 37, 4–27. DOI: 10.1177/1091581817741840. DOI: https://doi.org/10.1177/1091581817741840
8. Testa, G.; Giardina, S.M.C.; Culmone, A.; Vescio, A.; Turchetta, M.; Cannavò, S.; Pavone, V. Intra-Articular Injections in Knee Osteoarthritis: A Review of Literature. J. Funct. Morphol. Kinesiol. 2021, 6, Art. No: 15. DOI: 10.3390/jfmk6010015. DOI: https://doi.org/10.3390/jfmk6010015
9. Jones, I.A.; Togashi, R.; Wilson, M.L.; Heckmann, N.; Vangsness, C.T. Jr. Intra-articular treatment options for knee osteoarthritis. Nat. Rev. Rheumatol. 2019, 15, 77-90. DOI: 10.1038/s41584-018-0123-4. DOI: https://doi.org/10.1038/s41584-018-0123-4
10. El-Kadiry, A.E.; Lumbao, C.; Salame, N.; Rafei, M.; Shammaa, R. Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative study. BMC Musculoskelet Disord. 2022, 23, Art. No: 23. DOI: 10.1186/s12891-021-04910-5. DOI: https://doi.org/10.1186/s12891-021-04910-5
11. Xie, X.; Zhang, C.; Tuan, R.S. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res. Ther. 2014, 16, Art. No: 204. DOI: 10.1186/ar4493. DOI: https://doi.org/10.1186/ar4493
12. Szwedowski, D.; Szczepanek, J.; Paczesny, Ł.; Zabrzyński, J.; Gagat, M.; Mobasheri, A.; Jeka, S. The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis. Int. J. Mol. Sci. 2021, 22, Art. No: 5492. DOI: 10.3390/ijms22115492. DOI: https://doi.org/10.3390/ijms22115492
13. Khoshbin, A.; Leroux, T.; Wasserstein, D.; Marks, P.; Theodoropoulos, J.; Ogilvie-Harris, D.; Gandhi, R.; Takhar, K.; Lum, G.; Chahal, J. The Efficacy of Platelet-Rich Plasma in the Treatment of Symptomatic Knee Osteoarthritis: A Systematic Review With Quantitative Synthesis. Arthroscopy. 2013, 29, 2037–2048. DOI: 10.1016/j.arthro.2013.09.006. DOI: https://doi.org/10.1016/j.arthro.2013.09.006
14. Marmotti, A.; Rossi, R.; Castoldi, F,.; et al. PRP and articular cartilage: a clinical update. Biomed. Res. Int. 2015, 2015, Art. No: 542502. DOI: doi: 10.1155/2015/542502 DOI: https://doi.org/10.1155/2015/542502
15. Dohan Ehrenfest, D.M.; Andia, I.; Zumstein, M.A.; Chang-Qing, Z.; Pinto, N.R.; Bielecki, T. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014, 4, 3-9. DOI: https://doi.org/10.11138/mltj/2014.4.1.0013
16. Filardo, G.; Kon, E.; Pereira Ruiz, M.; Vaccaro, F.; Guitaldi, R.; Di Martino, A.; et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg. Sports Traumatol. Arthrosc. 2011, 20, 2082–2091. DOI: 10.1007/s00167-011-1837-x. DOI: https://doi.org/10.1007/s00167-011-1837-x
17. Braun, H.; Kim, H.; Chu, C.; Dragoo, J. The effect of platelet-rich plasma formulations and blood products on human synoviocytes. Am. J. Sports Med. 2014, 42, 1204–1210. DOI: 10.1177/0363546514525593. DOI: https://doi.org/10.1177/0363546514525593
18. Petrella, R.J.; Petrella, M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J. Rheumatol. 2006, 33, 951-956.
19. Cerza, F.; Carnì, S.; Carcangiu, A.; Di Vavo, I.; Schiavilla, V.; Pecora, A.; De Biasi, G.; Ciuffreda, M. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am. J. Sports Med. 2012, 40, 2822-2827. DOI: 10.1177/0363546512461902. DOI: https://doi.org/10.1177/0363546512461902
20. Dold, A.P.; Zywiel, M.G.; Taylor, D.W.; Dwyer, T.; Theodoropoulos, J. Platelet-rich plasma in the management of articular cartilage pathology: a systematic review. Clin. J. Sport Med. 2014, 24, 31-43. DOI: 10.1097/01.jsm.0000432855.85143.e5. DOI: https://doi.org/10.1097/01.jsm.0000432855.85143.e5
21. Abhishek, A.; Doherty, M. Mechanisms of the placebo response in pain in osteoarthritis. Osteoarthr. Cartil. 2013, 21, 1229–1235. DOI: 10.1016/j.joca.2013.04.018. DOI: https://doi.org/10.1016/j.joca.2013.04.018
22. Bennell, K.L.; Paterson, K.L.; Metcalf, B.R.; Duong, V.; Eyles, J.; Kasza, J.; Wang, Y.; Cicuttini, F.; Buchbinder, R.; Forbes, A.; Harris, A.; Yu, S.P.; Connell, D.; Linklater, J.; Wang, B.H.; Oo, W.M.; Hunter, D.J. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. 2021, 326, 2021-2030. DOI: 10.1001/jama.2021.19415. DOI: https://doi.org/10.1001/jama.2021.19415
23. Filardo, G.; Previtali, D.; Napoli, F.; Candrian, C.; Zaffagnini, S.; Grassi, A. PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. Cartilage. 2021, 13, 364S-375S. DOI: 10.1177/1947603520931170. DOI: https://doi.org/10.1177/1947603520931170
24. Zhao, J.; Huang, H.; Liang, G.; Zeng, L.F.; Yang, W.; Liu, J. Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020, 21, Art. No: 224. DOI: 10.1186/s12891-020-03262-w. DOI: https://doi.org/10.1186/s12891-020-03262-w
25. Raeissadat, S.A.; Ghazi Hosseini, P.; Bahrami, M.H.; Salman Roghani, R.; Fathi, M.; Gharooee Ahangar, A.; Darvish, M. The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial. BMC Musculoskelet Disord. 2021, 22, Art. No: 134. DOI: 10.1186/s12891-021-04017-x. DOI: https://doi.org/10.1186/s12891-021-04017-x
26. Joshi Jubert, N.; Rodríguez, L.; Reverté-Vinaixa, M.; Navarro, A. Platelet-rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double-blinded clinical trial. Orthop. J. Sports Med. 2017, 5, Art. No: 232596711668938. DOI: 10.1177/2325967116689386. DOI: https://doi.org/10.1177/2325967116689386
27. Phillips, M.; Bhandari, M.; Grant, J.; Bedi, A.; Trojian, T.; Johnson, A.; Schemitsch, E. A Systematic Review of Current Clinical Practice Guidelines on Intra-articular Hyaluronic Acid, Corticosteroid, and Platelet-Rich Plasma Injection for Knee Osteoarthritis: An International Perspective. Orthop. J. Sports Med. 2021, 9, Art. No: 23259671211030272. DOI: 10.1177/23259671211030272. DOI: https://doi.org/10.1177/23259671211030272
28. Shahid, M.; Kundra, R. Platelet-rich plasma (PRP) for knee disorders. EFORT Open Rev. 2017, 2, 28-34. DOI: 10.1302/2058-5241.2.160004. DOI: https://doi.org/10.1302/2058-5241.2.160004
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Katarzyna Łysiak, Anna Łysiak, Magdalena Makarewicz, Barbara Maziarz
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
